Stock listing

Verastem, Inc.

Selected listing: 2VSA · MUN · EUR · DE

Verastem, Inc. (Munich:2VSA), Health Technology. Latest release Oct 5, 2026: Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

2VSA:MUNEURDEUpdated October 2, 2026

Ticker: Munich:2VSA
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Munich
Currency: EUR

Latest news from Verastem, Inc.

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 5, 2026

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 4, 2026

Verastem Oncology Announces New RAMP 201 Molecular Profiling and External Control Arm Analyses Describing Outcomes for Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer to be Presented at IGCS 2026

October 1, 2026

Verastem Oncology Announces New RAMP 201 Molecular Profiling and External Control Arm Analyses Describing Outcomes for Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer to be Presented at IGCS 2026

October 2, 2026

Verastem Oncology Announces Publication in Gynecologic Oncology of Two-Year Median Follow-Up Data from RAMP 201 Study of AVMAPKI® FAKZYNJA® CO-PACK (avutometinib capsules; defactinib tablets) in Recurrent Low-Grade Serous Ovarian Cancer

September 28, 2026

All Verastem, Inc. news →

Events

Replays

Verastem, Inc. (VSTM) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 PM ET
Watch
Verastem, Inc. (VSTM) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Verastem, Inc. (VSTM) Q4 2025 Earnings Call
Wed, Mar 04, 2026 · 04:30 PM ET
Watch

Research Verastem, Inc.

Verastem, Inc. company profile

View the public company page for Verastem, Inc. on 6ix.

Verastem, Inc. news

Read company news and market updates connected to Verastem, Inc..

Verastem, Inc. investor events

Find investor webinars, events, and replay context for Verastem, Inc..